Factor VIII biosimilar - GenBioPro
Latest Information Update: 03 Jun 2015
At a glance
- Originator GenBioPro
- Class Antihaemorrhagics; Blood coagulation factors; Cyclic peptides; Granulocyte colony-stimulating factors; Growth hormones; Indoles; Recombinant erythropoietins; Recombinant proteins; Small molecules; Somatostatins
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia